Advanced Product Search

AffiKIT® C-MET IHC 1A1 Kit

AffiKIT® C-MET IHC 1A1 Kit

AffiKIT® Claudin18.2 IHC 3B10 Kit

AffiKIT® Claudin18.2 IHC 3B10 Kit

AffiKIT® Claudin18.2 IHC 3B10 Kit

AffiKIT® Creatinine Serum Low Sample Volume Kit (384-well Plate)

AffiKIT® EGFR IHC 5A6 Kit

AffiKIT® EGFR IHC 5A6 Kit

AffiKIT® EGFR IHC 5A6 Kit

AffiKIT® HER2 IHC 5D5 Kit

AffiKIT® HER2 IHC 5D5 Kit

AffiKIT® HER2 IHC 5D5 Kit

AffiKIT® PD-L1 IHC 5D3 Kit

AffiKIT® PD-L1 IHC 5D3 Kit

AffiKIT® PD-L1 IHC 5D3 Kit

AffiKIT® resDNA Sample Preparation Kit (Magnetic Beads)

AffiKIT®​ BrdU IHC Kit

AffiPATH®​ Brain tumor tissue microarray, 41 glioblastoma, 3 ependymoma, 2 each of ganglion glioma and gliosarcoma, 1 medulloblastoma) divided into two identical 96 core arrays, suitable for therapeutic antibody screening.

AffiPATH®​ Breast Tumor Tissue Array - 64 Different Breast tumors. Plus positive control and negative control

AffiPATH®​ Breast cancer tissue array (most of triple negative) including pathology grade, TNM and clinical stage replacing BR1202a

AffiPATH®​ Breast cancer tissue array (most of triple negative) including pathology grade, TNM, clinical stage

AffiPATH®​ Breast cancer tissue array (most of triple negative) including pathology grade, TNM, clinical stage

AffiPATH®​ Breast cancer tissue array (most of triple negative) including pathology grade, TNM, clinical stage, replacing BR1201a

AffiPATH®​ Breast cancer tissue array with lymph node positive and negative, with cancer adjacent tissue, including pathology grade, TNM and clinical stage

AffiPATH®​ Colon Tumor Matched Pair Tissue Array - 29 colon tumor/adjacent normal pairs. Plus positive control and negative control

AffiPATH®​ Colon Tumor Tissue Array - 64 Different Colon tumors. Plus positive control and negative control

AffiPATH®​ Colon cancer tissue microarray chip with survival data

AffiPATH®​ Combined microarray for osteosarcoma and chondrosarcoma with survival data, including TNM, survival status and clinical stage

AffiPATH®​ Diffuse large-B cell lymphoma and mucosa associated lymphoma tissue array, including GC/Non-GC type and IHC marker (Bcl-6, MUM1, CD10) replacing LY1001b

AffiPATH®​ Her-2 IHC Bio-marker control TMA, with breast invasive carcinoma of no special type, including pathology grade, TNM, replacing Her2b

AffiPATH®​ Liver disease spectrum tissue microarray, 20 cholangiocellular carcinoma, 5 metastatic cancer, 12 cirrhosis, 1 liver fibrosis, 2 hyperplasia, 10 hepatitis, 5 non-alcoholic fatty liver, 5 liver tissue, single core per case

AffiPATH®​ Lung Tumor Tissue Array - 64 Different Lung tumors. Plus positive control and negative control

AffiPATH®​ Lung carcinoma with lung tissue microarray, 3 adenosquamous carcinoma, 30 squamous cell carcinoma, 3 large cell carcinoma, 3 carcinoid, plus 5 lung tissue

AffiPATH®​ Lung small cell carcinoma and normal tissue microarray with survival data, including TNM and clinical stage

AffiPATH®​ Malignant melanoma tissue microarray, divided into two identical 12 core arrays for testing different antibody dilutions

AffiPATH®​ Malignant melanoma, metastatic malignant melanoma microarray with survival data and medication history, including TNM and clinical stage

AffiPATH®​ Mouse Digestive Tissue Frozen Microarray

AffiPATH®​ Mouse Digestive Tissue Paraffin Microarray

AffiPATH®​ Mouse Mixed Tissue Frozen Microarray, Panel #1

AffiPATH®​ Mouse Mixed Tissue Frozen Microarray, Panel #2

AffiPATH®​ Mouse Mixed Tissue Frozen Microarray, Panel #3,

AffiPATH®​ Mouse Mixed Tissue Paraffin Microarray, Panel #1

AffiPATH®​ Mouse Mixed Tissue Paraffin Microarray, Panel #2

AffiPATH®​ Mouse Mixed Tissue Paraffin Microarray, Panel #3

AffiPATH®​ Mouse Neuronal Tissue Frozen Microarray

AffiPATH®​ Mouse Neuronal Tissue Paraffin Microarray

AffiPATH®​ Mouse Reproductive Tissue Frozen Microarray

AffiPATH®​ Mouse Reproductive Tissue Paraffin Microarray

AffiPATH®​ Multiple Tumor Tissue Array - 7 different normal tissues and 5 major tumor types in duplicates for IHC antibody and ISH

AffiPATH®​ Ovary Tumor Tissue Array - 64 Different Ovary tumors. Plus positive control and negative control